1-16 of 16 results for subject:Zeneca
Librarians' tools
- Search time
- 0.308 seconds
- Solr query time
- 0.001 seconds
- Search query
- subject:Zeneca
- We searched for
- subject_t:Zeneca OR subject_t:"Zeneca Pharmaceuticals" OR subject_ses:86932
Type
+
Members' contributions (2)
-
Oral answers to questions (1)
-
Oral questions (1)
+
Parliamentary committees (9)
+
Committee proceedings (2)
-
Select Committee oral evidence (2)
-
Select Committee reports (7)
+
Parliamentary papers (9)
-
House of Commons papers (4)
-
House of Lords papers (5)
+
Parliamentary proceedings (2)
+
Debates (2)
+
Committee proceedings (2)
-
Select Committee oral evidence (2)
+
Parliamentary questions (6)
-
Oral questions (1)
-
Written questions (5)
House
Session
Year
Department
Member
Primary member
Answering member
Legislative stage
Legislation
Subject
More
Publisher
What employment contracts, consultancies (whole or part-time) or liaison arrangements have existed between the agrochemical companies Zeneca and Novartis of their predessors and the Medical Toxicology Unit (formerly the National Poisons Unit) since 1990; and how many of these arrangements are current. [HL 67].
What employment contracts, consultancies (whole or part-time) or liaison arrangements have existed between the agrochemical companies Zeneca and Novartis of their predessors and the Medical Toxicology Unit (formerly the National Poisons Unit) since 1990; and how many of these arrangements are current. [HL 67].
Asked by
Countess of Mar
(Crossbench)
Answered by
Lord Hunt of Kings Heath
(Labour)
Type
Written questions
Status
Answered
For answer on
15 January 2001
Answered on
15 January 2001
Subjects
Contracts; Consultants; Novartis; Zeneca; Medical Toxicology Unit
Date
15 January 2001
Reference
HL 67; 620 c110-1WA
House
House of Lords
To ask the Secretary of State for the Environment, Transport and the Regions, what assessment of potential environmental impact he undertook before permission was given to Zeneca to plant genetically-modified poplar trees near Bracknell.
To ask the Secretary of State for the Environment, Transport and the Regions, what assessment of potential environmental impact he undertook before permission was given to Zeneca to plant genetically-modified poplar trees near Bracknell.
Asked by
Norman Baker
(Liberal Democrat)
Answered by
Michael Meacher
(Labour)
Answering body
Department of the Environment, Transport and the Regions
Type
Written questions
Status
Answered
Tabled on
15 June 1999
For answer on
22 June 1999
Answered on
22 June 1999
Mr. Baker: To ask the Secretary of State for the Environment, Transport and the Regions what assessment of potential environmental
impact he undertook before permission was given to Zeneca to plant genetically modified poplar trees near Bracknell. [87604]
Mr. Meacher: Two consents have been issued to Zeneca Ltd. to plant small scale trials of genetically modified poplar trees in the
Bracknell area. Each application included a pre-planting environmental audit and risk assessment that were assessed by the Advisory
Committee on Releases to the Environment. The trees for both trials are derived from female clones and will not therefore produce
pollen. The trees will be coppiced after four years to ensure that they remain in a juvenile phase and do not flower and the trials
will be terminated prior to flowering after a further four years. In addition there is specific monitoring at both sites for
precocious flowering each spring and any flower buds are removed to prevent pollination. A copy of the consent documents and the
environmental risk assessment is available on the public register at the Department.
Subjects
Genetically modified organisms; Environmental impact assessment; Trees; Tree planting; Bracknell; Zeneca
Date
22 June 1999
Reference
333 c336W; 87604
House
House of Commons
To ask the Secretary of State for the Environment, Transport and the Regions, if he will require the Health Safety Executive to institute prosecution proceedings against Zeneca for a breach of the regulations governing the escape into the environment, through the consumption by Zeneca staff of genetically-modified tomatoes and tomato...
To ask the Secretary of State for the Environment, Transport and the Regions, if he will require the Health Safety Executive to institute prosecution proceedings against Zeneca for a breach of the regulations governing the escape into the environment, through the consumption by Zeneca staff of genetically-modified tomatoes and tomato...
Asked by
Norman Baker
(Liberal Democrat)
Answered by
Michael Meacher
(Labour)
Answering body
Department of the Environment, Transport and the Regions
Type
Written questions
Status
Answered
Tabled on
23 February 1999
For answer on
1 March 1999
Answered on
1 March 1999
Mr. Baker: To ask the Secretary of State for the Environment, Transport and the Regions if he will require the Health Safety
Executive to institute prosecution proceedings against Zeneca for a breach of the regulations governing the escape into the
environment, through the consumption by Zeneca staff of genetically modified tomatoes and tomato seeds. [73402]
Mr. Meacher: HSE inspectors have sought clarification from Zeneca regarding reports in the national press that members of staff have
eaten whole genetically modified tomatoes as part of taste trials. If this had taken place it would have represented a possible
breach of environmental safety regulations. This is because tomatoes are a seed bearing fruit and the inadvertent dispersal of seeds
from genetically modified tomatoes could have given rise to growth of genetically modified plants in the environment. The concern
would have been that seeds would have dispersed through the sewage system, thereby breaching containment requirements.
It has been found that there were major inaccuracies in the reporting. In particular, it would appear that taste trials have only
been undertaken using tomato tissues from which all seeds have been removed. Therefore, there would not appear to have been any
breach of environmental safety legislation.
The photograph of Zeneca staff eating whole tomatoes, which appeared in one newspaper, was posed for the cameras using non-modified
tomatoes.
Subjects
Genetically modified organisms; Health and Safety Executive; Food; Prosecutions; Safety; Tomatoes; Zeneca
Date
1 March 1999
Reference
326 c509W; 73402
House
House of Commons
To ask the Minister of Agriculture, Fisheries and Food, if he will list the meetings his Department has held with (a) Monsanto, (b) AgrEvo, (c) Novartis, (d) Zeneca and (e) other representatives of the biotechnology industry relating to biotechnology. - Inc list and ref to 31 March 1998, 309 c505-8W.
To ask the Minister of Agriculture, Fisheries and Food, if he will list the meetings his Department has held with (a) Monsanto, (b) AgrEvo, (c) Novartis, (d) Zeneca and (e) other representatives of the biotechnology industry relating to biotechnology. - Inc list and ref to 31 March 1998, 309 c505-8W.
Asked by
Alan Simpson
(Labour)
Answered by
Lord Rooker
(Labour)
Answering body
Ministry of Agriculture Fisheries and Food
Type
Written questions
Status
Answered
Tabled on
11 June 1998
For answer on
22 June 1998
Answered on
22 June 1998
Mr. Alan Simpson: To ask the Minister of Agriculture, Fisheries and Food if he will list the meetings his Department has held with
(a) Monsanto, (b) AgrEvo, (c) Novartis, (d) Zeneca and (e) other representatives of the biotechnology industry relating to
biotechnology. [46211]
Mr. Rooker: Neither I nor my colleagues have held any meeting with companies from the biotechnology industry since 1 May 1997. In
addition to the meetings detailed in my reply to the hon. Member for Lewes (Mr. Baker) on 31 March 1998, Official Report, columns
505-08, officials have met representatives of biotechnology companies on the occasions listed.
_________________________________________________________________________________________________.
Date Company
1997
21 May Pioneer Hi-Bred International Inc. USA
28 May Novartis
4 June CPB Twyford
30 June Sharpes/KWS
11 July Plant Breeding Institute
18 July AgrEvo
8 October Nickerson BIOCEM
21 October Plant Breeding Institute, Zeneca, Nickerson BIOCEM and Advanced
Technologies (Cambridge) Ltd.
31 October Monsanto
1998
5 January Plant Genetic Systems
14 January AgrEvo, Cynamid, Monsanto and Novartis
15 January CPB Twyford
11 February Advanta
16 February Zeneca
11 March AgrEvo, Cynamid, Monsanto and Novartis
24 March Monsanto
6 May Zeneca
15 May Monsanto, AgrEvo and other biotechnology companies
20 May Plant Genetic Systems
22 May Monsanto, AgrEvo and other biotechnology companies
9 June AgrEvo, Cynamid and Monsanto
17 June Monsanto, AgrEvo and other biotechnology companies
_________________________________________________________________________________________________.
In addition, the Veterinary Medicines Directorate meets regularly with representatives of pharmaceutical companies as part of its
responsibilities for the authorisation of veterinary medicines in the UK.
Subjects
Biotechnology; Monsanto; Novartis; AgrEvo; Zeneca
Date
22 June 1998
Reference
314 c419-20W; 46211
House
House of Commons
Type
Select Committee reports; House of Lords papers;
Parliamentary committees
Committee
European Communities Committee
Notes
Received 23.06.98
Subjects
Law Society of Scotland; EU action; Law Society; Patents; Patent Office; Chartered Institute of Patent Agents; Confederation of British Industry; Association of the British Pharmaceutical Industry; British Retail Consortium; Bioindustry Association; Intellectual Property Institute; Zeneca; Intellectual Property Lawyers Association; Trade Marks Patents and Designs Federation; Burnside, Michael; Jacob, Robin; Aldous, William; Pumfrey, Nicholas; Brinkhof, Jan J; Cornish, WR; Laddie, High
Date
9 June 1998
Reference
HL 115 1997/98
House
House of Lords
To ask the Minister of Agriculture, Fisheries and Food, if he will list the occasions since 1st May when he, his colleagues, or officials, have (a) met and (b) received representations from (i) Monsanto and (ii) Zeneca; what matters were discussed; and if he will comment on the outcome of...
To ask the Minister of Agriculture, Fisheries and Food, if he will list the occasions since 1st May when he, his colleagues, or officials, have (a) met and (b) received representations from (i) Monsanto and (ii) Zeneca; what matters were discussed; and if he will comment on the outcome of...
Asked by
Norman Baker
(Liberal Democrat)
Answered by
Lord Rooker
(Labour)
Answering body
Ministry of Agriculture Fisheries and Food
Type
Written questions
Status
Answered
Tabled on
25 March 1998
For answer on
31 March 1998
Answered on
31 March 1998
Mr. Baker: To ask the Minister of Agriculture, Fisheries and Food if he will list the occasions since 1 May when he, his colleagues,
or officials, have (a) met and (b) received representations from (i) Monsanto and (ii) Zeneca; what matters were discussed; and if
he will make a statement on the outcome of each meeting. [36879]
Mr. Rooker: [holding answer 30 March 1998]: Neither I nor my colleagues have met either of these two companies since 1 May. However,
officials met or received representations from them on the following occasions
(i) Monsanto
_________________________________________________________________________________________________.
Date Reason Outcome
16 May 1997 Meeting to discuss an application under EC Agreement to submit an application
Novel Foods Regulation
18 June 1997 9 July 1997 19 August 1997 Meetings to discuss matters relation of Improved understanding of requirements
pesticides
11 September 1997 Letter in response to consultation Comments noted
exercise on herbicide tolerant crops
23 September 1997 8-9 October 1997 31 Meetings to discuss matters relating to Improved understanding of requirements
October 1997 17-18 November 1997 18-19 the regulation of pesticides.
November 1997 28 November 1997 5 December
1997
23 January 1998 Meeting to discuss segregation and Exchange of views
labelling of GMOs
11 February 1998 To discuss matters relating to the Improved understanding of requirements
regulation of pesticides
24 March 1998 Courtesy visit from Senior Vice President Exchange of views
responsible for GMO issues
_________________________________________________________________________________________________.
(ii) Zeneca
_________________________________________________________________________________________________.
Date Reason Outcome
1 May 1997 12 May 1997 13 May 1997 2-6 June Meetings to discuss matters relating to Improved understanding of requirements
1997 the regulation of pesticides
4 June 1997 Meeting to discuss a possible application Notification of company's intention to
under EC Novel Foods Regulation submit application in due course
16 June 1997 18 June 1997 30 June/1 July Meetings to discuss matters relating to Improved understanding of requirements
1997 2 July 1997 9 July 1997 14 July 1997 18 the regulation of pesticides
July 1997 13-14 August 1997
13 August 1997 Meeting to discuss an application under EC Agreement to submit an application
Novel Foods Regulation
9 September 1997 Letter in response to consultation Comments noted
exercise on herbicide tolerant GMOs
23 September 1997 6 October 1997 8-9 October Meetings to discuss matters relating to Improved understanding of requirements
1997 14 October 1997 19 October 1997 25 the regulation of pesticides
October 1997 27-28 October 1997 31 October
1997 17-18 November 1997 19 November 1997 27
November 1997 16 December 1997 26-27 January
1998 30 January 1998 13 February 1998 26
February 1998 4 March 1998
_________________________________________________________________________________________________.
In addition, 2 officials had a short placement with Zeneca in the Autumn of 1997.
Subjects
Monsanto; Zeneca
Date
31 March 1998
Reference
309 c506-8W; 36879
House
House of Commons
Type
Select Committee reports; House of Lords papers;
Parliamentary committees
Committee
Science and Technology Committee (HL)
Subjects
Animals; Costs; Antibiotics; Agency nurses; Hospitals; Finance; Licensing; ICT; Diseases; Drugs; Infectious diseases; HIV/AIDS; Health education; General practitioners; Hormones; Northern Ireland; Prisons; Pharmacy; Marketing; Medicine; Prescriptions; MRSA; Scotland; Training; Research; Testing; Vaccination; Students; USA; Sweden; Tuberculosis; Viral diseases; Scottish Office; Meningitis; Salmonella; Malaria; Medical Research Council; Monsanto; Royal Society; Royal Pharmaceutical Society of Great Britain; Soil Association; Pneumonia; Campylobacter; SmithKline Beecham; Veterinary Medicines Directorate; E. coli; Royal College of Nursing; Royal College of Pathologists; Chief Medical Officer for Northern Ireland; National Anti-vivisection Society; Society for General Microbiology; St George's Hospital Medical School; Zeneca; Ministry of Agriculture, Fisheries and Food; British Association for Chemical Specialities; Research Council for Complementary Medicine; Scottish Microbiology Association; UK Agricultural Supply Trade Association; UK National Committee for Microbiology; North Middlesex University Hospital; Southsea; Soothill; Enterococcus; Ulmanis, G; Sterland, J; Kennedy, HF; vanSaene, KF; Sweeney, EJ; Michie, JR; Piddock, LJV; Spencer, RC; Tyrrell, D; Griffin, GE; Watt, B
Commons Library location
Research Sc 574.19246,P
Date
17 March 1998
Reference
HL 81 1997/98
House
House of Lords
Answered by
Gerald Malone
(Conservative)
Answering body
Department of Health
Type
Oral answers to questions
Subjects
Zeneca
Date
14 May 1996
Reference
277 c753
Chamber / Committee
House of Commons chamber
House
House of Commons
Supplementary on Zeneca plc pharmaceuticals company.
Supplementary on Zeneca plc pharmaceuticals company.
Asked by
Nicholas Winterton
(Conservative)
Answering body
Department of Health
Oral questions - 1st Supplementary
Status
Answered
Answered on
14 May 1996
Subjects
Zeneca
Date
14 May 1996
Reference
277 c753
Chamber / Committee
House of Commons chamber
House
House of Commons
Type
Select Committee reports; House of Commons papers;
Parliamentary committees
Committee
Trade and Industry Committee
Notes
Received 20.07.95
Subjects
Aviation; Arms trade; British Gas; Education; Exports; UK Export Finance; Overseas trade; British Airways; National Grid Company; European Commission; Biwater; Rolls-Royce; British Petroleum; EU external relations; Mercosur; Trafalgar House; Argentina; Brazil; British Council; Confederation of British Industry; HSBC Group; Trade promotion; British Consultants and Construction Bureau; London Chamber of Commerce and Industry; Babcock International; Society of Motor Manufacturers and Traders; Zeneca; Latin America; Brazilian Chamber of Commerce in Great Britain; Liverpool Chamber of Commerce and Industry; Brazilian Embassy; Bain Hogg International; British Water; British Embassy Brasilia; BZW; Kennedy and Co; Peek Traffic; GEC
Commons Library location
CS 340;Stats 410.8
Date
12 July 1995
Reference
HC 374 1994/95
House
House of Commons
Type
Select Committee reports; House of Commons papers;
Parliamentary committees
Committee
Science and Technology Committee
Subjects
Church of Scotland; Genetics; Ethics; Medicine; National Consumer Council; Research; Royal College of Surgeons of England; Pfizer; Biotechnology and Biological Sciences Research Council; Wellcome Trust; SmithKline Beecham; Royal College of Pathologists; Methodist Church; Religious Society of Friends; Alzheimer's Disease Society; Cancer Research Campaign; Royal College of Midwives; Human Genome Organisation; Progress Educational Trust; United Free Church of Scotland; Zeneca; Biochemical Society; Clinical Molecular Genetics Society; Dystrophic Epidermolysis Bullosa Research Association; Friedreichs Ataxia Group; Free Church Federal Council; Genetic Research Instrument; Huntington's Disease Association; National Free Church Women's Council; Royal Institution of Great Britain; Sequana Therapeutics; Tepnel Life Sciences; Therexsys; Clothier, Cecil; Davies, Kay; Crawford, Alex; Sanger, F; Humphries, Steve; Johnstone, EveC; Turner, R; Brock, D; Anionwu, Elizabeth; Hastie, Nick; Kearns, Mary; Denison, Keith; Reid, Marjorie McEwan; Cox, T; Falder, P; Wolpert, Lewis; Harnden, DG; Dexter, TM; Little, P; Ferguson-Smith, MA; Hodgson, S; Ponder, Bruce; Harris, Adrian L; Bell, Sir John
Date
6 July 1995
Reference
HC 41 1994/95
House
House of Commons
Type
House of Lords papers; Select Committee oral evidence;
Parliamentary committees
Committee
Science and Technology Committee (HL)
Subjects
Administration; NHS; Medicine; Research; Association of the British Pharmaceutical Industry; University of Leicester; Zeneca
Date
15 February 1995
Reference
HL 12-vii 1994/95
House
House of Lords
Type
Select Committee reports; House of Commons papers;
Parliamentary committees
Committee
Health Committee
Subjects
Cost effectiveness; Costs; Contraceptives; Finance; Drugs; NHS; Prescription drugs; Age Concern; Consumers Association; Mersey Regional Health Authority; Medicines Resource Centre; South East Thames Regional Health Authority; Cancer Research Campaign; Fisons; Cystic Fibrosis Trust; Derbyshire Family Health Services Authority; Medical Advisers Support Centre; National Council for Hospice and Specialist Palliative Care Services; Zeneca; Evans, David; Caremark; American Pharmaceutical Group; Arachnoiditis Self Help Group; Barnet Family Health Services Authority; British Geriatrics Society; Bristol Myers Squibb Pharmaceuticals; Cilag; Dispensing Doctors Association; Eastern Region Pharmaceutical Group; European Society of Cardiology; Guild of Hospital Pharmacists; Lederle Laboratories; London and Thames Valley Pharmaceutical Group; Mersey Academic Pharmacy Practice Unit; REMIT Consultants; Rhône-Poulenc; Society for Endocrinology; Women in Medicine; Thomas, David; Howie, JGR; Patch, Malcolm; Furber, Tony; Newton, Rogers
Commons Library location
CS 598
Date
7 July 1994
Reference
HC 80 1993/94
House
House of Commons
Type
Select Committee reports; House of Lords papers;
Parliamentary committees
Committee
European Communities Committee
Notes
Received 17.03.94
Subjects
Department of Trade and Industry; Biotechnology; Law Society of Scotland; Inventions; Patents; National Farmers Union; Greenpeace; Agricultural and Food Research Council; Chartered Institute of Patent Agents; Association of the British Pharmaceutical Industry; Medical Research Council; Wellcome Foundation; British Union for the Abolition of Vivisection; British Society of Plant Breeders; Bioindustry Association; National Farmers Union of Scotland; Compassion in World Farming; Zeneca; British Biotechnology; Clinical Genetics Society
Date
1 March 1994
Reference
HL 28 1993/94
House
House of Lords
Type
House of Commons papers; Select Committee oral evidence;
Parliamentary committees
Committee
Science and Technology Committee
Notes
Received 20.10.93
Subjects
Innovation; Technology; Research; Science; SmithKline Beecham; Zeneca; British Biotechnology
Commons Library location
CS 902
Date
14 July 1993
Reference
HC 654-viii 1992/93
House
House of Commons
Type
Select Committee reports; House of Lords papers;
Parliamentary committees
Committee
Science and Technology Committee (HL)
Notes
Received 11.05.93
Subjects
Chemicals; Biotechnology; Genetic engineering; Genetically modified organisms; Drugs; Industry; Regulation; Research; Glaxo; Zeneca
Date
1 April 1993
Reference
HL 80-iii 1992/93
House
House of Lords